Skip to content
March is Autoimmune Awareness Month, and with an estimated 50 million people in the U.S. affected by autoimmune disease—and numbers continuing to increase—raising awareness […]
Autoimmune Awareness Month highlights diseases impacting 50M in U.S. Read More »
As part of BIO’s March Patient Advocacy Coffee Chat, Thomas Heymann, President & CEO of Sepsis Alliance, spoke about sepsis—a life-threatening condition caused by
Sepsis and AMR: Understanding the connection and the growing threat to public health Read More »
Despite women making up half the population, women’s health has historically been “woefully underfunded,” accounting for less than 5% of products in the biotech
Women’s History Month: What’s the story with women’s health investment? Read More »
Patient perspectives are vital to inform health policy. One agency where such input is particularly crucial is the Centers for Medicare and Medicaid Services
Patient organization engagement of CMS is more important than ever Read More »
The Food and Drug Administration’s (FDA) Rare Pediatric Disease Priority Review Voucher (PPRV) Program was top of mind during BIO’s March Patient Advocacy Coffee
March 8th is International Women’s Day and to mark the occasion, Bio.News is exploring an under researched field of women’s health – autoimmune diseases
International Women’s Day: Improving women’s health by addressing autoimmune disease Read More »
The time has come for Congress to pass legislation to prevent pharmacy benefit managers (PBMs) from inflating drug costs, limiting patient access to drugs,
House members urge passage of reforms at PBM hearing Read More »
Bipartisan legislation reintroduced in the House on Feb. 21 would encourage the development of small-molecule drugs by eliminating the “pill penalty” in the Inflation
EPIC Act introduced to correct IRA’s ‘pill penalty’ Read More »
“Kidney disease is a major and growing public health concern,” LaVarne A. Burton, American Kidney Fund President and CEO, said in an interview with
Kidney Action Week: 4 things you need to know about kidney disease Read More »
The Centers for Medicare & Medicaid Services (CMS) recently announced the 2025 selection of 15 drugs covered under Medicare Part D for price “negotiations”
The role of the patient voice in CMS drug price ‘negotiation’ Read More »
